Background: The effects of furosemide on left atrial pressure (LAP) in dogs with mitral regurgitation (MR) have not been documented in a quantitative manner and between different routes of administration.Objective: To document LAP and echocardiographic parameters in MR dogs administered furosemide IV or PO, in order to document changes in LAP after furosemide treatment.Animals: Five healthy Beagle dogs (3 males and 2 females; aged 2 years) were used. Methods: Experimental, cross-over, and interventional study. LAP was measured before the administration of furosemide, and 30 minutes, 1, 1.5, 2, 3, 4, 5, 6, 8, 12, and 24 hours after administration. Furosemide 1, 2, or 4 mg/kg IV, PO or placebo was administered.Results: LAP was significantly decreased with all administrations of furosemide but not after placebo (P o .05, respectively). The max reduction was observed 1 hour (1 mg/kg IV, 15.04 AE 7.02 mmHg), 3 hours (2, 4 mg/kg IV, 13.28 AE 8.01, 9.23 AE 4.92 mmHg), 4 hours (1 mg/kg PO, 14.68 AE 11.51 mmHg), and 5 hours (2, 4 mg/kg PO, 13.19 AE 10.52, 10.70 AE 7.69 mmHg). E wave and E/Ea were significantly decreased corresponding to the reduction of LAP after administration of 2 and 4 mg/kg (P o .05, respectively).Conclusions and Clinical Importance: LAP was decreased in proportion to the dosage of furosemide, which did not significantly differ between IV and PO of the same dosages. E wave and E/Ea might be useful for the treatment evaluation of furosemide.Key words: Radio telemetry system; Total circulating blood volume; Transmitral blood flow.M itral valve disease is the most common cardiac disease in dogs. As many as three quarters of all dogs with signs of congestive heart failure suffer from mitral regurgitation (MR) caused by myxomatous degeneration of the valve leaflets or the chordae tendineae.1,2 MR increases the left atrial pressure (LAP) which potentially results in left atrial dilation. Elevated LAP causes pulmonary edema that can lead to cough, dyspnea, and even death.3 Therefore, LAP needs to be reduced to avoid these clinical signs.Furosemide, a loop diuretic, has a strong diuretic effect and is commonly used for the treatment of pulmonary edema in patients with MR. 4 Furosemide reduces the total circulating blood volume, which in turn reduces the LAP or the left ventricular filling pressure, and leads to the clinical improvement of the patients. [5][6][7][8][9] There are several administration routes for furosemide, including IV, PO, SC, and IM. Pharmacokinetics of furosemide has been compared between IV and PO administration. However, the effects of furosemide on LAP in dogs with MR have not been well documented in a quantitative manner because there are some difficulties in measuring LAP directly. We have previously reported the 24-hour LAP profiles of and the effect of angiotensin-converting enzyme (ACE) inhibitors on experimentally induced MR dogs with a radio telemetry system. 10,11 The previous study has demonstrated that this system is useful for the evaluation of hemodynamic changes that occur...